pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Strona główna・Stock List・Beam Therapeutics Inc
Search

Beam Therapeutics Inc

Open

Sector Healthcare

22.21 -1.24

Buy

Price update 29 paź 2024, 14:48 UTC

BuySell

Overview

Share price change

24h

Current

Min

21.79

Max

22.39

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+114.77 upside

News Sentiment

By Acuity

50%

50%

190 / 389 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

21.5 / 22.74 Support & Resistance

Beam Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 paź 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

DJ

Read

26 wrz 2024, 14:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. -- IBD

DJ

Read

24 lis 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

DJ

Read

31 paź 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

DJ

Read

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

114.77% upside

12 Months Forecast

Average 48 USD  114.77%

High 80 USD

Low 24 USD

Based on 10 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

5

Buy

5

Hold

0

Sell

Based on 10 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

21.5 / 22.74Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Weak Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

190 / 389 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

904.26

↑ +0.95%

UNH

UnitedHealth Group Inc

562.18

↓-0.6%

NVO

Novo Nordisk A-S

112.01

↓-0.39%

JNJ

Johnson and Johnson

160.15

↓-0.86%

ABBV

AbbVie Inc

189.51

↓-0.07%